1.
MMW Fortschr Med
; 141(25): 62, 1999 Jun 24.
Article
in German
| MEDLINE
| ID: mdl-10897913
2.
Clin Ther
; 10(5): 585-8, 1988.
Article
in English
| MEDLINE
| ID: mdl-2485240
ABSTRACT
Twenty men, aged 50 to 75 years (mean, 67 years), suffering from benign prostatic hypertrophy received 160 mg of a lyposterolic extract of Serenoa repens, twice daily for 30 days. Before and at the end of treatment, plasma levels of testosterone, follicle-stimulating hormone, and luteinizing hormone were determined. No changes in plasma hormone levels occurred as a result of treatment. It is concluded that Serenoa extract, which is useful in the treatment of benign prostatic hypertrophy, does not act via systemic changes of hormone levels.